A new preprint discusses how novel tuberculosis vaccines for adolescents and adults could mitigate this problem.
Shimadzu Corporation establishes three R&D centers in the US in anticipation of business expansion for pharmaceutical companies
Japan’s Shimadzu Corporation announced this month that its US subsidiary, Shimadzu Scientific Instruments (SSI), has established a new R&D center in the US, and is